CARLOS
TAXONERA SAMSO
Profesor asociado
Pfizer (United States)
Nueva York, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von Pfizer (United States) (2)
2024
-
Clinical settings with tofacitinib in ulcerative colitis
Revista Espanola de Enfermedades Digestivas, Vol. 116, Núm. 9, pp. 484-492
2022
-
Cost-effectiveness analysis of using innovative therapies for the management of moderate-to-severe ulcerative colitis in Spain
Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 22, Núm. 1, pp. 73-83